| Moxifloxacin Analytical Method Validation-Assay |
| Method Parameter |
Method & Intermediate Precision combined |
| Method Precision |
|
Intermediate Precision |
|
|
|
|
| S.No. |
% Drug
content |
S.No. |
% Drug
content |
Difference |
Average of both
Method &
Intermediate
precision |
STDEV of both
Method &
Intermediate
precision |
%RSD of both
Method &
Intermediate
precision |
| 1 |
101.04 |
1 |
99.2 |
1.8 |
99.9 |
0.730 |
0.73 |
| 2 |
100.46 |
2 |
99.3 |
1.2 |
| 3 |
99.81 |
3 |
99.4 |
0.4 |
| 4 |
101.16 |
4 |
99.2 |
2.0 |
| 5 |
100.34 |
5 |
100.1 |
0.2 |
| 6 |
99.64 |
6 |
99.0 |
0.6 |
| Limits: Overall RSD when compared with Method precision should be not more than 2%. |
